Palvella TherapeuticsPVLA
那斯達克 · USD
150.13
-0.26
(-0.17%)
收盤 09/12 03:59 (UTC+8)
09/12 03:59 (UTC+8)
Palvella TherapeuticsPVLA
150.13
-0.26
(-0.17%)
財務數據
損益表
- -
- 0.00
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | |
營業收入淨額 | - | - | - | - | - | - | - | - | 53 | - |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | - | - | - | - | - | - | - | - | 53 | - |
營業費用 | 21,405 | 14,855 | 11,304 | 10,177 | 9,250 | - | 4,366 | 3,135 | 7,774 | 1,759 |
研發費用 | 12,473 | 9,334 | 7,121 | 6,528 | 5,118 | 4,074 | 2,543 | -446 | 985 | 984 |
推銷及管理費用 | 8,932 | 5,521 | 4,183 | 3,649 | 4,132 | 3,797 | 1,823 | 3,581 | 6,789 | 775 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -21,405 | -14,855 | -11,304 | -10,177 | -9,250 | -7,871 | -4,366 | -3,135 | -7,721 | -1,759 |
其他收入及費用 | 1,843 | 1,127 | 2,399 | -1,728 | -309 | 901 | -1,807 | 248 | 970 | 28 |
利息費用 | 2,308 | 2,039 | 1,739 | 1,510 | 1,354 | 1,215 | -2,583 | - | -805 | 805 |
稅前純益 | -21,870 | -15,767 | -12,714 | -11,345 | -9,471 | -8,185 | -3,951 | -2,887 | -5,946 | -2,536 |
所得稅 | - | - | - | - | - | - | - | - | - | - |
稅後純益 | -21,870 | -15,767 | -12,714 | -11,345 | -9,471 | -8,185 | -3,951 | -2,887 | -5,946 | -2,536 |
基本每股稅後盈餘(元) | -1.52 | -1.20 | -1.08 | -1.03 | -0.86 | -0.74 | - | -0.62 | -0.39 | -0.24 |
稀釋每股稅後盈餘(元) | -1.54 | -1.20 | -1.08 | -1.03 | -0.86 | -0.74 | 0.12 | -3.94 | -2.47 | -1.54 |
基本平均股數(千股) | 14356.00 | 13085.00 | 11876.00 | 11064.00 | 11052.00 | 11013.00 | - | 11221.00 | 11221.00 | 11221.00 |
稀釋平均股數(千股) | 14356.00 | 13085.00 | 11876.00 | 11064.00 | 11052.00 | 11013.00 | - | 11221.00 | 11221.00 | 11221.00 |
還原基本每股稅後盈餘(元) | -1.52 | -1.20 | -1.08 | -1.03 | -0.86 | -0.74 | - | -0.62 | -0.39 | -0.24 |
還原稀釋每股稅後盈餘(元) | -1.54 | -1.20 | -1.08 | -1.03 | -0.86 | -0.74 | 0.12 | -3.94 | -2.47 | -1.54 |
還原基本平均股數(千股) | 14,356 | 13,085 | 11,876 | 11,064 | 11,052 | 11,013 | - | 11,221 | 11,221 | 11,221 |
還原稀釋平均股數(千股) | 14,356 | 13,085 | 11,876 | 11,064 | 11,052 | 11,013 | - | 11,221 | 11,221 | 11,221 |
EBITDA(千元) | -19,882 | -13,743 | -10,975 | -9,835 | -8,117 | -6,970 | -6,534 | -2,887 | -6,781 | -1,731 |